Market Place
Sourcing Support
Enforcement Report for Week of June 28, 2023
28 Jun 2023 //
FDA
Enforcement Report - Week of December 28, 2022
28 Dec 2022 //
FDA
Enforcement Report - Week of April 6, 2022
06 Apr 2022 //
FDA
Aurolife Pharma Receives FDA Warning Letter
25 Nov 2020 //
FDA
India`s Aurolife under water with the FDA after chronic leaks imperil generics
24 Nov 2020 //
FIERCE PHARMA
Aurolife Pharma`s Generic Oxycodone Hydrochloride Receives Approval in US
27 Jan 2020 //
FDA
Enforcement Report - Week of September 25, 2019
26 Sep 2019 //
FDA
Aurobindo recalls mislabeled statin tablets from the U.S. market
10 Sep 2019 //
FIERCE PHARMA
Aurobindo says company, subsidiary made party to litigation proceeding in US
06 Jun 2019 //
MONEYCONTROL
Aurolife Pharma Withdrawal of Approval of 31 Abbreviated New Drug Applications
19 Apr 2019 //
FEDERALREGISTER
Aurolife Pharma `s Generic Amphetamine Sulfate Receives Approval in US
19 Apr 2019 //
FDA
Aurolife Pharma `s Generic Methylphenidate HCl Receives Approval in US
02 Nov 2018 //
FDA
Aurolife Pharma `s Generic Glycopyrrolate Receives Approval in US
31 Oct 2018 //
FDA
Enforcement Report - Week of May 23, 2018
23 May 2018 //
FDA
CorePharma to reopen under new ownership following Impax sale
31 Jan 2018 //
OUTSOURCING
Aurolife Pharma`s Generic Lorazepam Receives Approval In US
27 Dec 2017 //
FDA
Aurolife Pharma Llc ANDA Omeprazole & Sodium Bicarbonate Approved in USA
21 Aug 2016 //
FDA
Aurolife`s Generic Hydromorphone HCl approved in US as an opioid analgesic
13 May 2016 //
FDA
Aurobindo Pharma gets USFDA nod for two generic drugs
18 Jan 2016 //
ECONOMIC TIMES
Aurobindo Pharma receives USFDA Approval for Norethindrone Acetate Tablets
11 Jan 2016 //
AUROBINDO PHARMA
Aurobindo Pharma gets USFDA nod for generic hypertension tablets
04 Sep 2015 //
THE ECONOMIC TIMES
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.